Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction

NCT06433427 is registered in ClinicalTrials.gov with University Hospital of Ferrara as lead sponsor.

NCT NCT06433427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06433427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction
Lead sponsor
University Hospital of Ferrara
Phase
Observational
Overall status
Unknown status
Start date
May 29, 2024
Completion date
February 22, 2026
Enrollment
75 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aging, chronic disease, frailty, mitochondrial dysfunction